<!DOCTYPE html>
<html lang="en">
	<head>
		<meta charset="utf8">
		<meta name="viewport" content="width=device-width, initial-scale=1">
		<title>Risteys – L12_PSORIASIS – detailed case counts by code</title>
		<style type="text/css">
body {
	font-family: sans-serif;
}
.bar-plot-full {
	width: 8rem;
	border-radius: 0.1rem;
	background-color: #f2f2f2;
}
.bar-plot-full div {
	background-color: #c7c7c7;
	height: 1rem;
	border-radius: 0.1rem;
}
		</style>
	</head>
	<body>

		<table>
			<tr>
				<th>Source</th>
				<th>Code</th>
				<th>Name</th>
				<th>Case count</th>
				<th>Share of cases (%)</th>
			</tr>

			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(L400)</td>
					<td>Psoriasis vulgaris</td>
					<td>4960</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 61.424148606811144%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(L405)</td>
					<td>Arthropathic psoriasis (M07.0-M07.3*, M09.0*)</td>
					<td>2834</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 35.09597523219814%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(L40)</td>
					<td>Psoriasis. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>1496</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 18.526315789473685%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(L400)</td>
					<td>Psoriasis vulgaris. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>1474</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 18.25386996904025%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(L405)</td>
					<td>Arthropathic psoriasis (M07.0-M07.3*, M09.0*). Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>1437</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 17.795665634674922%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(L405)</td>
					<td>Arthropathic psoriasis (M07.0-M07.3*, M09.0*)</td>
					<td>977</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 12.099071207430342%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(L403)</td>
					<td>Pustulosis palmaris et plantaris</td>
					<td>947</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 11.727554179566564%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(L400)</td>
					<td>Psoriasis vulgaris</td>
					<td>889</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 11.009287925696594%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(L403)</td>
					<td>Pustulosis palmaris et plantaris. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>729</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 9.027863777089783%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(L409)</td>
					<td>Psoriasis, unspecified. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>717</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 8.879256965944272%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(L409)</td>
					<td>Psoriasis, unspecified</td>
					<td>524</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 6.489164086687306%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(L408)</td>
					<td>Other psoriasis</td>
					<td>463</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 5.733746130030959%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD8(69619)</td>
					<td>Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)</td>
					<td>419</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 5.188854489164087%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(L409)</td>
					<td>Psoriasis, unspecified</td>
					<td>309</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.8266253869969042%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(6961A)</td>
					<td>Psoriasis and similar disorders, Other psoriasis</td>
					<td>301</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.7275541795665634%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(L404)</td>
					<td>Guttate psoriasis</td>
					<td>296</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.6656346749226008%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(L408)</td>
					<td>Other psoriasis. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>292</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.616099071207431%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(319)_ICD10(L400)</td>
					<td>Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis), Psoriasis vulgaris</td>
					<td>250</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 3.0959752321981426%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(6960A)</td>
					<td>Psoriatic arthropathy</td>
					<td>220</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 2.7244582043343657%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(134)_ICD10(L400)</td>
					<td>General erythroderma, Psoriasis vulgaris</td>
					<td>148</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.8328173374613004%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(L404)</td>
					<td>Guttate psoriasis. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>131</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.6222910216718265%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD8(69600)</td>
					<td>Psoriasis and similar disorders, Psoriatic arthropathy</td>
					<td>107</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.325077399380805%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(L403)</td>
					<td>Pustulosis palmaris et plantaris</td>
					<td>96</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.1888544891640866%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(L40)</td>
					<td>Psoriasis</td>
					<td>96</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.1888544891640866%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(L408)</td>
					<td>Other psoriasis</td>
					<td>91</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 1.1269349845201238%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(L401)</td>
					<td>Generalized pustular psoriasis</td>
					<td>62</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.7678018575851393%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Outpatient Hilmo">OUTPAT</abbr></td>
					<td>OUTPAT_ICD10(L402)</td>
					<td>Acrodermatitis continua</td>
					<td>45</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.5572755417956656%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(L404)</td>
					<td>Guttate psoriasis</td>
					<td>37</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.4582043343653251%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(6961D)</td>
					<td>Psoriasis and similar disorders, Other psoriasis</td>
					<td>30</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.37151702786377705%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD8(68693)</td>
					<td>Other local infections of skin and subcutaneous tissue, Pustulosis palmo-plantaris</td>
					<td>28</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.34674922600619196%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(L401)</td>
					<td>Generalized pustular psoriasis</td>
					<td>21</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.26006191950464397%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(377)_ICD10(L400)</td>
					<td>Apremilast and dimethyl fumarate (psoriasis), Psoriasis vulgaris</td>
					<td>21</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.26006191950464397%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(L40)</td>
					<td>Psoriasis</td>
					<td>19</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.2352941176470588%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(L401)</td>
					<td>Generalized pustular psoriasis. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>19</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.2352941176470588%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD9(6961B)</td>
					<td>Psoriasis and similar disorders, Other psoriasis</td>
					<td>9</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.11145510835913312%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD10(L402)</td>
					<td>Acrodermatitis continua</td>
					<td>8</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.09907120743034056%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Inpatient Hilmo">INPAT</abbr></td>
					<td>INPAT_ICD8(69610)</td>
					<td>Psoriasis and similar disorders, Psoriasis pustulosa</td>
					<td>8</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.09907120743034056%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(281)_ICD10(L400)</td>
					<td>Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab, Psoriasis vulgaris</td>
					<td>8</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.09907120743034056%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Cause of death">DEATH</abbr></td>
					<td>DEATH_ICD10(L405)</td>
					<td>Arthropathic psoriasis (M07.0-M07.3*, M09.0*)</td>
					<td>7</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.08668730650154799%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="KELA drug reimbursment">REIMB</abbr></td>
					<td>REIMB_KELA(313)_ICD10(L400)</td>
					<td>Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases), Psoriasis vulgaris</td>
					<td>7</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.08668730650154799%"></div>
						</div>
						
					</td>
				</tr>
			
				<tr>
					<td><abbr title="Avohilmo: Primary healthcare outpatient">PRIM_OUT</abbr></td>
					<td>PRIM_OUT_NOT_USED_ICD10(L402)</td>
					<td>Acrodermatitis continua. Not used in endpoint definition. POSSIBLY INACCURATE IN COMPLEX ENDPOINTS!</td>
					<td>5</td>
					<td>
						
						<div class="bar-plot-full">
							<div style="width: 0.061919504643962855%"></div>
						</div>
						
					</td>
				</tr>
			

		</table>

	</body>
</html>
